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178 ( ADA -American Diabetes Association, ACC/AHA -American College of Cardiology/American Heart Association, HS -High School, eGFR -Estimated glomerular filtration rate, ACR -Albumin-to-creatinine ratio, CVD -Cardiovascular disease, ASCVD -Atherosclerotic cardiovascular disease. * High CVD risk was defined as a history of cardiovascular disease or a 10-year predicted atherosclerotic cardiovascular disease risk ≥ 10%. † This category included participants with systolic blood pressure between 130 and 139 mm Hg or diastolic blood pressure between 80 and 89 mm Hg with systolic blood pressure < 140 mm Hg and diastolic blood pressure < 90 mm Hg. † † Mean 10-year atherosclerotic cardiovascular disease risk was calculated among participants without a history of cardiovascular disease. † † † Mean 30-year atherosclerotic cardiovascular disease risk was calculated among participants 20 to 59 years of age without a history of cardiovascular disease Overall concordance: 90.8% (88.1%, 93.0%) Overall discordance: 9.2% (7.0%, 11.9%)
Estimates from NHANES data using definitions from the 2017 American College of Cardiology/American Heart Association blood pressure guideline and the American Diabetes Association diabetes and hypertension position statement.
In this sensitivity analysis, goal blood pressure was defined as: -2017 American College of Cardiology/American Heart Association blood pressure guideline: systolic blood pressure < 130 mm Hg and diastolic blood pressure < 80 mm Hg for all individuals. -American Diabetes Association diabetes and hypertension position statement: systolic blood pressure < 130 mm Hg and diastolic blood pressure < 80 mm Hg for those with history of cardiovascular disease or 10-year predicted cardiovascular disease risk ≥ 20% and systolic blood pressure < 140 mm Hg and diastolic blood pressure < 90 mm Hg for individuals without a history of cardiovascular disease and with a 10-year predicted cardiovascular disease risk < 20%. ACC/AHA -American College of Cardiology/American Heart Association; ADA -American Diabetes Association Supplementary Table 4 . Characteristics of US adults with diabetes taking antihypertensive medication with above goal blood pressure according to the ACC/AHA blood pressure guideline and the ADA diabetes and hypertension position statement Above goal blood pressure according to: Neither ACC/AHA BP guideline or ADA position statement(n=523) ACC/AHA BP guideline but not ADA position statement (n=47 ADA -American Diabetes Association, ACC/AHA -American College of Cardiology/American Heart Association, HS -High School, eGFR -Estimated glomerular filtration rate, ACR -Albumin-to-creatinine ratio, CVD -Cardiovascular disease, ASCVD -Atherosclerotic cardiovascular disease. † The group without above goal blood pressure according to either the ACC/AHA guideline or ADA position statement had systolic blood pressure < 130 mm Hg and diastolic blood pressure < 80 mm Hg. † † The group with above goal blood pressure according to the ACC/AHA guideline but not the ADA position statement had systolic blood pressure of 130 to 139 mm Hg with diastolic blood pressure < 90 mm Hg or diastolic blood pressure of 80 to 89 mm Hg with systolic blood pressure < 140 mm Hg and did not have high cardiovascular disease risk. † † † The group with above goal blood pressure according to the ACC/AHA guideline and the ADA position statement had systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg or had high cardiovascular disease risk and systolic blood pressure ≥ 130 mm Hg or diastolic blood pressure ≥ 80 mm Hg. ‡ Mean 10-year atherosclerotic cardiovascular disease risk was calculated among participants without a history of cardiovascular disease. * High CVD risk was defined as a history of cardiovascular disease or a 10-year predicted atherosclerotic cardiovascular disease risk ≥ 10%. ‡ ‡ Mean 30-year atherosclerotic cardiovascular disease risk was calculated among participants 20 to 59 years of age without a history of cardiovascular disease
